Novel selective cannabinoid CB(1) receptor antagonist MJ08 with potent in vivo bioactivity and inverse agonistic effects

AIM: To characterize the biological profiles of MJ08, a novel selective CB(1) receptor antagonist. METHODS: Radioligand binding assays were performed using rat brain and spleen membrane preparations. CB(1) and CB(2) receptor redistribution and intracellular Ca(2+) ([Ca(2+)](i)) assays were performed...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chen, Wei, Xu, Cheng, Liu, Hong-ying, Long, Long, Zhang, Wei, Zheng, Zhi-bing, Xie, Yun-de, Wang, Li-li, Li, Song
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2011
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4003302/
https://ncbi.nlm.nih.gov/pubmed/21841814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2011.80
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items